Allen Institute for Artificial Intelligence
supp.ai logo
supp.ai

Discover Supplement-Drug Interactions

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 3 years ago

Possible Interaction: Oxymetazoline and Yohimbine

supplement:

Yohimbine

Research Papers that Mention the Interaction

A concentration (CONCopt) of oxymetazoline and prazosin was calculated from these curves that would optimally antagonize binding of [3H]yohimbine to high-affinity sites, minimally inhibiting low-affinity binding.
The percentages of [3H]yohimbine binding that were inhibited by the CONCopt of oxymetazoline and prazosin were determined in numerous brain regions.
The Journal of pharmacology and experimental therapeutics  •  1993  |  View Paper
Moreover, the positive effects of oxymetazoline were attenuated by yohimbine and BRL44408, which are selective alpha2- and alpha2A-adrenoceptor antagonists, respectively.
Biological & pharmaceutical bulletin  •  2020  |  View Paper
A presynaptically supramaximal concentration of the α-adrenergic agonist oxymetazoline prevented the facilitatory action of yohimbine , but not that of angiotensin II.
Naunyn-Schmiedeberg's Archives of Pharmacology  •  2004  |  View Paper
Both detomidine and oxymetazoline inhibited vagal acid hypersecretion, their effects being fully prevented by idazoxan, 7,8-(methylenedioxy)-14-alpha-hydroxyalloberbane (CH 38083), or 2-(2-methoxy-1,4-benzodioxan-2-yl)-2-imidazoline (RX 821002), and partly antagonized by yohimbine or rauwolscine.
European journal of pharmacology  •  1995  |  View Paper
The emesis induced by oxymetazoline , tramazoline, xylazine, naphazoline and epinephrine was also antagonized by a selective alpha-2 adrenoceptor antagonist, yohimbine , but not by a selective alpha-1 adrenoceptor antagonist, prazosin.
The Journal of pharmacology and experimental therapeutics  •  1992  |  View Paper
Activation of the enzyme by oxymetazoline was prevented by either the alpha 1-adrenergic antagonist prazosin or the alpha 2-adrenergic antagonist yohimbine and was mimicked by the calcium ionophore A23187.
Proceedings of the National Academy of Sciences of the United States of America  •  1992  |  View Paper
3 The α1‐adrenoceptor agonist, oxymetazoline and the antagonist prazosin inhibited the binding of [3H]‐yohimbine to rat cortex in a complex manner consistent with an interaction at more than one site.
British journal of pharmacology  •  1990  |  View Paper
4 Yohimbine (0.03–1.0 μM) and phentolamine (0.1–5.0 μM) shifted to the right the concentration‐response curve of oxymetazoline for the inhibition of [3H]‐noradrenaline overflow in response to nerve stimulation without depressing the maxima.
5 Yohimbine (0.1 μM) also antagonized the decrease induced by oxymetazoline in the postsynaptic responses to nerve stimulation.
British journal of pharmacology  •  1983  |  View Paper
The antisecretory effects of oxymetazoline and clonidine given intracerebroventricularly were antagonized with yohimbine administered by the same route.
Naunyn-Schmiedeberg's archives of pharmacology  •  1982  |  View Paper
Yohimbine readily blocked the inhibitory effects of clonidine, oxymetazoline and noradrenaline in both tissues but was less effective against dopamine and apomorphine.
European journal of pharmacology  •  1979  |  View Paper